Toxic epidermal necrolysis, commonly shortened to TEN, is a rare but extremely serious medical emergency in which large areas of skin blister, die, and detach from the body. The reaction also frequently attacks moist tissues known as mucous membranes, including the mouth, eyes, genitals, urinary tract, and airways.
Most cases are triggered by a medication. The immune system essentially mistakes the body’s own skin cells for troublemakers and launches an attack with all the restraint of a smoke alarm reacting to burnt toastexcept this response is genuinely dangerous. TEN can cause severe pain, dehydration, infection, organ damage, vision problems, and death, so symptoms require immediate hospital care.
TEN belongs to the same disease spectrum as Stevens-Johnson syndrome. The difference is primarily the amount of detached or severely damaged skin: Stevens-Johnson syndrome affects less than 10% of the body surface, an overlap condition affects 10% to 30%, and toxic epidermal necrolysis affects more than 30%.
Understanding the SJS/TEN Spectrum
Stevens-Johnson syndrome and toxic epidermal necrolysis were once described as separate illnesses. Today, clinicians generally view them as different levels of severity within the same severe cutaneous adverse reaction.
- Stevens-Johnson syndrome: Less than 10% of the body surface is detached or threatened.
- SJS/TEN overlap: Between 10% and 30% of the body surface is affected.
- Toxic epidermal necrolysis: More than 30% of the body surface is affected.
The percentage is medically important, but TEN is not simply a “large rash.” The upper layer of skin, called the epidermis, separates from the layer beneath it. Raw, exposed areas may resemble a severe burn even though no heat caused the damage.
The mouth, lips, eyes, nose, throat, genitals, and urinary tract may become inflamed, blistered, or ulcerated. Involvement of the respiratory tract can interfere with breathing. Because the skin normally controls fluid loss, body temperature, and protection against germs, widespread detachment creates multiple emergencies at once.
What Causes Toxic Epidermal Necrolysis?
Medication reactions
Medications are responsible for most cases of TEN. In a multicenter study involving 377 adults treated at 18 academic medical centers in the United States, nearly 90% of SJS/TEN cases were attributed to medication reactions.
Drugs most frequently associated with SJS/TEN include:
- Sulfonamide antibiotics, including trimethoprim-sulfamethoxazole
- Antiseizure medications such as carbamazepine, lamotrigine, phenytoin, and phenobarbital
- Allopurinol, a medicine commonly used for gout
- Certain nonsteroidal anti-inflammatory drugs, especially oxicam-type NSAIDs
- Some other antibiotics
- Nevirapine and certain other antiviral medications
- Occasionally, cancer therapies and immune-modifying drugs
This list does not mean that most people taking these medications will develop TEN. The reaction is exceptionally rare. It also does not mean that every ordinary rash caused by medication is TEN. However, a painful or rapidly spreading rash accompanied by blisters, fever, facial swelling, mouth sores, or eye irritation should never be treated as a “let’s see how it looks tomorrow” situation.
When does TEN begin after taking a medication?
Symptoms often appear one to four weeks after a person begins a new medication. The timing may be shorter if the immune system has encountered the drug before. This delay can make identifying the culprit difficult, especially when someone recently started several medications or took short courses of antibiotics, pain relievers, or over-the-counter products.
Infections and other uncommon triggers
A smaller number of cases may be associated with infections, particularly in children. Mycoplasma pneumoniae, respiratory infections, and certain viral illnesses have been linked to SJS-like mucosal disease. Rare associations include vaccination, graft-versus-host disease, and cases in which no definitive trigger is found.
Why Does the Immune System Attack the Skin?
The exact biological sequence is still being studied, but TEN is generally considered a severe immune-mediated reaction. Cytotoxic T cells and natural killer cells release inflammatory substances that trigger the death of keratinocytes, the main cells in the epidermis.
As large numbers of keratinocytes die, the epidermis loses its structure and separates. One molecule involved in this process is granulysin, which can damage skin and mucosal cells. Other immune pathways involving tumor necrosis factor, Fas ligand, and additional inflammatory signals may also contribute.
In plain English, the immune system receives the wrong instructions, identifies skin cells as enemies, and responds far more aggressively than the situation calls for.
Who Is at Higher Risk?
TEN can affect children and adults of any age. Certain factors, however, may increase susceptibility or worsen the outcome:
- A previous episode of Stevens-Johnson syndrome or TEN
- HIV infection
- Systemic lupus erythematosus or another chronic inflammatory disorder
- Cancer or a weakened immune system
- Older age
- Use of several medications at the same time
- Certain inherited HLA gene variants
Some medication risks vary by genetic ancestry. For example, the HLA-B*15:02 variant is strongly associated with carbamazepine-related SJS/TEN in people from several Asian populations. HLA-B*58:01 is associated with severe reactions to allopurinol. Clinicians may recommend genetic testing before prescribing particular drugs to patients with relevant ancestry or risk factors.
Having a risk-associated gene does not guarantee that TEN will occur. Most people with these variants never develop the condition. Genetics is one piece of a complicated puzzle, not a fortune cookie predicting your dermatologic future.
Early Symptoms of Toxic Epidermal Necrolysis
TEN commonly begins with symptoms that resemble influenza or another respiratory illness. These early signs may appear before the skin reaction becomes obvious:
- Fever
- Fatigue or unusual weakness
- Headache
- Muscle aches
- Sore throat
- Cough
- Burning or red eyes
Within hours or days, more distinctive symptoms may develop:
- Intense or widespread skin pain
- A red, purple, or dusky rash that spreads quickly
- Flat spots that merge into larger areas
- Blisters
- Skin that peels or slips away with light pressure
- Painful sores in the mouth or throat
- Crusted, swollen, or bleeding lips
- Eye redness, pain, light sensitivity, or discharge
- Painful urination or genital sores
- Difficulty swallowing or breathing
Skin pain can be an especially important warning sign. Many ordinary rashes itch. TEN is often strikingly tender or painful, sometimes before dramatic peeling begins.
When should someone seek emergency care?
Call emergency services or go to an emergency department immediately when a new or recently used medication is followed by a rapidly spreading rash, painful skin, blisters, peeling, mouth sores, eye symptoms, facial swelling, fever, or breathing difficulty.
Bring a complete list of prescription drugs, over-the-counter medicines, supplements, and recently discontinued products. Medication start dates are particularly helpful. TEN is a medical emergency that usually requires hospitalization, and early withdrawal of a suspected medication can improve the chance of survival.
How Is Toxic Epidermal Necrolysis Diagnosed?
Diagnosis begins with the appearance and distribution of the skin and mucosal injuries, the speed of progression, and the patient’s medication history. Doctors estimate how much body surface is detached or at risk of detaching.
A skin biopsy is often performed. A small tissue sample can show widespread death of epidermal cells and help distinguish TEN from conditions such as:
- Staphylococcal scalded skin syndrome
- Erythema multiforme
- Autoimmune blistering diseases
- Acute generalized exanthematous pustulosis
- DRESS syndrome
- Thermal or chemical burns
Blood tests help evaluate kidney function, liver function, electrolytes, blood cell counts, blood sugar, acid-base balance, and signs of infection. Cultures may be collected if sepsis is suspected. Doctors also examine the eyes, mouth, airway, lungs, urinary tract, and genital tissues.
What is SCORTEN?
SCORTEN is a clinical scoring system used to estimate the risk of death in patients with TEN. It considers seven factors, including age, heart rate, cancer, affected body surface, blood urea nitrogen, blood glucose, and bicarbonate levels.
The score does not determine an individual’s destiny. It helps medical teams recognize high-risk patients, communicate severity, and plan the intensity of monitoring and supportive care.
How Is Toxic Epidermal Necrolysis Treated?
Stopping the suspected medication
The first crucial step is identifying and immediately discontinuing the likely triggering medication under emergency medical supervision. Nonessential medications may also be stopped while clinicians reconstruct the treatment timeline.
Intensive supportive care
Patients are typically treated in an intensive care unit, specialized dermatology unit, or burn center. Supportive care gives the skin and mucous membranes the safest possible environment in which to heal.
Treatment may include:
- Intravenous fluids and electrolyte replacement
- Nutritional support, sometimes through a feeding tube
- Careful wound cleansing and nonstick dressings
- Strong pain relief
- Temperature control
- Monitoring for sepsis and organ dysfunction
- Respiratory support if the airway or lungs are involved
- Mouth care to reduce pain and maintain nutrition
- Urinary and genital care to limit scarring
The care team may include dermatologists, burn specialists, critical-care physicians, nurses, pharmacists, ophthalmologists, gynecologists, urologists, respiratory specialists, dietitians, and rehabilitation professionals. TEN is not a one-doctor show; it is closer to a carefully coordinated medical orchestra.
Eye treatment
Early ophthalmology evaluation is essential, even when eye symptoms initially appear mild. Inflammation can produce adhesions, severe dryness, eyelid abnormalities, corneal injury, scarring, and permanent vision loss.
Treatment may include frequent lubrication, removal of inflammatory debris, topical medications, and other protective measures. In severe cases, specialists may place amniotic membrane tissue over the eye surface during the acute phase to reduce inflammation and scarring.
Medications that modify the immune response
Supportive care and removal of the triggering drug remain the foundations of treatment. Clinicians may also consider systemic corticosteroids, cyclosporine, intravenous immune globulin, etanercept, or other immune-modifying therapies.
No single medication is universally accepted as the best treatment for every patient. TEN is rare, making large clinical trials difficult, and study results have sometimes conflicted. Treatment decisions depend on disease timing, severity, infection risk, organ function, local expertise, and the patient’s overall condition. Routine preventive antibiotics are generally avoided unless there is evidence of infection.
Possible Complications
The loss of the skin barrier and damage to mucous membranes can affect nearly every organ system. Acute complications include:
- Severe dehydration
- Electrolyte abnormalities
- Low blood pressure and shock
- Sepsis
- Pneumonia or respiratory failure
- Kidney or liver injury
- Internal bleeding
- Multiple-organ failure
Long-term complications may include:
- Dry, sensitive, or discolored skin
- Abnormal nails or permanent nail loss
- Hair loss
- Reduced sweating or excessive sweating
- Chronic eye dryness, light sensitivity, corneal damage, or vision loss
- Dry mouth, dental problems, altered taste, or difficulty swallowing
- Genital or urinary scarring
- Chronic lung problems
- Anxiety, depression, sleep disturbances, or post-traumatic stress
Follow-up should therefore extend beyond skin healing. Survivors may require ongoing eye care, dental care, gynecologic or urologic evaluation, pulmonary testing, pain management, physical therapy, and mental health support.
What Is the Prognosis for TEN?
TEN is life-threatening, but survival is possible, particularly when the condition is recognized early and the suspected medication is stopped promptly. Published mortality estimates vary according to age, underlying health, extent of skin loss, organ involvement, treatment setting, and the population studied.
Some clinical references report mortality of approximately 25% to 35% among adults, while rates can be substantially higher in patients with extensive disease, advanced age, cancer, sepsis, or organ failure. Children generally have lower mortality than older adults.
New skin may begin covering exposed areas over several weeks, but full recovery can take months. Skin healing is only one milestone. Eye problems, fatigue, weakness, nutritional challenges, pain, emotional distress, and fear of future medication use may continue long after discharge.
Can Toxic Epidermal Necrolysis Be Prevented?
Not every case can be predicted, but recurrence prevention is essential. After a suspected drug is identified, survivors should:
- Never take the culprit drug again unless a highly specialized medical team determines that the original diagnosis was incorrect
- Avoid closely related medications when advised by an allergist, dermatologist, or pharmacist
- Make sure the reaction is clearly recorded in every medical chart
- Tell doctors, dentists, pharmacists, and emergency clinicians about the history
- Carry a medical alert card or wear medical identification
- Keep a written record of the suspected drug, reaction date, and hospital diagnosis
- Ask whether family members need genetic counseling or testing before using certain high-risk medications
Patients should not intentionally retry a suspected drug to “confirm” the allergy. With TEN, curiosity can be catastrophically overrated.
Conclusion
Toxic epidermal necrolysis is a rare, rapidly progressing immune reaction that destroys large areas of skin and mucous membranes. It is most often triggered by medication and is considered the most severe end of the Stevens-Johnson syndrome spectrum.
Early symptoms may resemble the flu, but the appearance of skin pain, a spreading dusky rash, blisters, peeling, mouth sores, or eye inflammation signals a medical emergency. Prompt hospitalization, immediate withdrawal of the suspected drug, meticulous supportive care, and early attention to the eyes and other mucosal surfaces can improve survival and reduce permanent complications.
The central message is simple: a painful, blistering rash after starting a medication should never be ignored. TEN is rare, but when it appears, minutes matter more than home remedies, search-engine reassurance, or optimistic waiting.
Experiences Related to Toxic Epidermal Necrolysis: A Composite Patient Journey
The following account is a representative composite based on commonly reported clinical and recovery experiences. It does not describe one identifiable patient.
The experience may begin in a way that feels almost ordinary. A person starts a new medication for an infection, seizure disorder, or gout. A week or two later, they develop a fever, sore throat, exhaustion, and burning eyes. They assume they have the flu. The medication does not seem connected because the first dose was taken days earlier, and the skin still looks reasonably normal.
Then the skin becomes strangely painful. Clothing feels abrasive. A shower feels hotter than it should. Red patches appear on the chest or face and spread over several hours. The lips swell and crack. Eating becomes difficult because the mouth feels raw. By the time blisters form, the situation has changed from “annoying illness” to “something is seriously wrong.”
In the emergency department, the patient may repeat the names of every recent medication while clinicians examine the skin, eyes, mouth, and airway. Photographs may be taken to document progression. Blood is drawn repeatedly. A biopsy is performed. Specialists arrive one after another, and the patient may be transferred to an intensive care unit or burn center.
The hospital experience can be physically and emotionally overwhelming. Wound care hurts even when everyone is gentle. Eating may be impossible, so nutrition arrives through a tube. Bright light can irritate inflamed eyes. Nurses carefully reposition the body to protect damaged skin. Family members may have to wear protective clothing, and conversations become brief because speaking is painful.
Many survivors describe uncertainty as one of the hardest parts. The medical team may not immediately know which drug caused the reaction. Skin changes can continue after the medication is stopped because the immune response is already in motion. Each day may bring new questions: Is the rash still spreading? Are the kidneys working normally? Are the eyes developing scar tissue? Is an infection beginning?
Improvement is usually gradual rather than cinematic. There is rarely a single morning when everything is suddenly fine. Instead, the temperature stabilizes. Fewer new blisters appear. Laboratory results improve. The skin begins to regenerate. Drinking water becomes possible, then soft food. Sitting up takes less effort. Eventually, the patient moves from intensive care to a regular hospital room and later returns home.
Homecoming can be joyful and unsettling at the same time. Skin may remain sensitive, darker, lighter, or unusually dry. Nails can loosen. Eyes may need drops throughout the day. Fatigue may turn simple tasksshowering, dressing, walking to the kitcheninto scheduled events. Follow-up appointments occupy the calendar, and every new medication label can trigger anxiety.
Emotional recovery deserves the same seriousness as physical recovery. Some survivors replay memories of wound care or fear falling asleep. Others become nervous whenever they develop a minor rash. Counseling, support groups, clear medication records, and a written emergency plan can restore a sense of control.
Over time, many people return to work, school, family activities, and routines. Recovery may not mean forgetting the experience. It may mean learning how to live confidently with better medication safeguards, reliable medical follow-up, and the knowledge that surviving TEN required both excellent clinical care and remarkable personal endurance.
Medical note: This article provides general educational information and cannot diagnose a skin reaction. Anyone experiencing painful skin, rapidly spreading rash, blisters, peeling, mouth sores, eye pain, facial swelling, or breathing problems after taking medication should seek emergency medical care immediately.
